Hematopoietic stem cell transplantation for classical inherited bone marrow failure syndromes: an update. Issue 10 (3rd October 2021)

• Record Type: Journal Article
• Authors: Pierri, Filomena; Faraci, Maura; Giardino, Stefano; Dufour, Carlo
• Is Part Of: Expert review of hematology. Volume 14:Issue 10(2021)
• Page Start: 911
• Page End: 925
• Publication Date: 2021-10-03
• Subjects: Inherited bone marrow failure syndromes -- hematopoietic stem cell transplantation -- conditioning regimen -- donor type -- stem cells source; Hematology -- Periodicals; 616.15005
• DOI: 10.1080/17474086.2021.1977119
• Languages: English
• ISSNs: 1747-4086

Abstract

ABSTRACT: Introduction: Inherited bone marrow failure syndromes (IBMFS) feature complex molecular pathophysiology resulting in ineffective hematopoiesis and increased risk of progression to myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Allogenic hematopoietic stem cell transplantation (HSCT) is the only well-established cure for the hematological manifestations of these diseases. Areas covered: In recent years, analysis of large series from international databases (mainly from the European Bone Marrow Transplantation [EBMT] database) has improved knowledge about HSCT in IBMFS. This review, following a thorough Medline search of the pertinent published studies, reports the most recent data on HSCT in IBMFS. Expert opinion: Despite the common features, IBMFS are very different in their manifestations and in the occurrence and management of HSCT complications. Thus, a 'disease-specific' HSCT using an optimized conditioning regimen based on the characteristics of the disease is essential for achieving long-term survival. The phenotypical heterogeneity associated with extramedullary abnormalities has to be carefully evaluated before HSCT because transplantation may only correct impaired hematopoiesis. HSCT may be associated with the risk of treatment-related mortality and with significant early and late morbidity. For these reasons, the benefits should be carefully weighed against the risks.